ClinicalTrials.gov
public full text
Public Domain
Effect of a Booster Dose of the Japanese Encephalitis Vaccine IC51
The objective is to assess the effect of a booster vaccination on immunogenicity of IC51 in terms of seroconversion rate.
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Examining the Effectiveness of Japanese Local and National Government Information Sources on COVID-19 Vaccine Uptake.#472517
- The INFLUENTIAL Trial- Evaluation of National Inpatient Influenza Vaccination Program#268072
- Immunogenicity of a JE-CV as a Booster Dose After a Primary Vaccination With SA14-14-2 Vaccine#1088566
- SARS-CoV-2 Infection in COVID-19 Vaccinated Patients#1101993
- Fluad vs. Fluzone High-Dose Vaccine Effectiveness Among Adults ≥65 Years#321635
Record · ID 1100680
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive